The comparative analysis of T cell subsets highlighted that, overall, CLL patients have a higher percentage of CD39+ lymphocytes than controls, both in the CD4+ and in the CD8+ compartment. Here, ENTPD1 is linked to B-cell chronic lymphocytic leukemia.